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ABSTRACT
During viral infection, the virus and host must compete for resources inside the
cell. One of these resources is polyamines. Polyamines are small, positively charged
molecules that are found in all eukaryotic cells. They play a key role in several cellular
functions including growth and proliferation, transcription and translation, and
membrane stability. Viruses also rely polyamines for productive replication, utilizing
them during DNA/RNA polymerization, nucleic acid packaging, and protein synthesis. In
response to a virus infecting a host cell, the host cell will begin to regulate polyamine
levels as a way to combat the infection. Polyamine levels are regulated by several
different enzymes, including SAT1. SAT1 acetylates polyamines to form acetyl
derivatives leading to degradation or excretion of the polyamines and therefore,
rendering them useless to the virus. The virus, in turn needs to combat this to continue
infection. Recent studies suggest that one way the virus does this is by splicing the
polyamine regulatory enzymes’ genes before they can be transcribed. We found that
Zika virus, a flavivirus, may alter SAT1 splicing and activity. We hypothesize that ZIKV
induced alternative splicing of the SAT1 gene generates an enzyme that is
nonfunctional allowing robust virus infection by disrupting polyamine depletion.
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CHAPTER ONE
BACKGROUND
Review of Literature
Zika Virus: An Overview
Zika virus (ZIKV) has recently gained a lot of attention due to the 2016 outbreak
in which the virus spread to over 80 countries becoming the focus of a public health
emergency. ZIKV was first isolated in 1947 at Yellow Fever Research Institute in Zika
Forest, Uganda. Until 2007, only 14 human cases were identified, and these originated
in Southeast Asia and Africa (1). The first outbreak of the virus occurred in Yap (Federal
States of Micronesia) in 2007. Due to the similarities of clinical symptoms, the disease
was originally diagnosed as chikungunya, dengue, or Ross River disease until
specimens from patients revealed the RNA of ZIKV. Approximately 73% of Yap’s
population was infected in this outbreak (2). Since then outbreaks have occurred in
French Polynesia (3), New Caledonia, Easter Island, the Cook Islands, and numerous
Latin American countries. By March of 2015, Brazil had between 500,000-1,500,000
ZIKV cases (4). By 2016, the World Health Organization declared ZIKV disease a public
health emergency of international concern. As of 2018 a total of 86 countries have
reported evidence of ZIKV disease (Figure 1). Since then the number of infections has
slowly declined with cases staying persistent at low levels in some areas (5).
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Figure 1. Reported Cases of ZIKV.
The map indicates reported cases of ZIKV infection in 2017. The purple represents
areas with active transmission in 2017, the orange represents areas affected in 2017,
and the yellow represents areas with ZIKV infection reported before 2015 (5).
ZIKV is an arbovirus and is spread primarily by Aedes mosquitos, however some
reports have found Anopheles, Ertmapodites (6), Culex, and Mansonia (7) species can
also be vectors. ZIKV can also be transmitted by blood transfusion, sexual contact, and
vertically from mother to child during pregnancy (8) (Figure 2). Most cases present
symptoms 3-12 days after infection. Nearly 80% of cases are asymptomatic. Case
fatalities and severe illness are rare consequences of ZIKV infection. Symptoms tend to
be non-specific, mild, and self-limiting. They include mild fever, dermatological rashes,
joint pain, and headache. The most common of these symptoms is the skin rash which
is seen in 90% of cases and often lasts 4-5 days. Hospitalization from ZIKV infection is
rare (9).
The major complications associated with ZIKV infection is congenital
microcephaly and Guillain-Barre syndrome. Guillain-Barre syndrome is a rare disorder
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in which the immune system damages nerves resulting in muscle weakness and
sometimes paralysis. This is due to high levels of protein in the cerebrospinal fluid (10).
In regions affected by the ZIKV epidemic, the incident rate of Guillain-Barre syndrome
was 20-fold higher than that of not affected areas (2). Primary microcephaly is defined
as a head circumference more than 3 standard deviations below the mean at birth.
Symptoms include hearing loss, development delay, seizure disorder, and cerebral
palsy. The risk of microcephaly is greatest in the first trimester of pregnancy.
Researchers have reported ZIKV in amniotic fluid and in placental cells (11). ZIKV first
infects the placenta and then the neural progenitor cells in the developing fetus. This
decreases the neural progenitor cells viability and growth through down-regulation of
genes involved in cell and organ development and up-regulation of genes involved in
immune responses. This ultimately results in inhibited cellular proliferation and
differentiation, neuronal apoptosis, and thinning of the cortex (12).
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Figure 2. Transmission of ZIKV.
Arrows represent transmission direction. Transmission of ZIKV is primarily by mosquito
bites but instances of sexual transmission have been reported as have cases of
infection by blood transfusion. ZIKV can also be passed from mother to fetus in the
womb.
ZIKV is a member of the Flaviviridae family. Other members include dengue
virus, West Nile virus, and yellow fever virus. Like all members of this family, ZIKV has a
positive sense single stranded RNA genome approximately 11 kb in size. ZIKV is
spherical in shape with an icosahedral like arrangement of surface proteins and is
approximately 50nm in diameter. The RNA of the virion is infectious and acts as viral
mRNA and viral genome (13).
The lifecycle of ZIKV follows that of most flaviviruses. The virus enters the cells
when the virion attaches to the cell membrane of the host via an envelope protein that
induces endocytosis. Once inside the host cell, the viral membrane fuses with the
endosomal membrane and the RNA is released into the cytoplasm. This RNA is then
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translated into a polyprotein which is involved in the formation of all structural and nonstructural proteins. Replication of the RNA then occurs in the cytoplasmic viral factories
of the ER which produces double stranded RNA. This double stranded RNA then
undergoes transcription to form additional single stranded RNA. This new single
stranded RNA is then assembled in the ER to form new virions. These virions are
ultimately transferred to the Golgi and released and go on and infect new cells (14)
(Figure 3). ZIKV, as for all viruses, relies on host machinery and resources during its
replication.

Figure 3. Flavivirus Replication Cycle.
The virus enters the cells when the virion attaches to the cell membrane of the host via
an envelope protein that encourages endocytosis. The viral membrane fuses with the
endosomal membrane and the RNA is released into the cytoplasm. This RNA is then
translated into a polyprotein which is involved in the formation of all structural and nonstructural proteins. Replication of the RNA then occurs in the cytoplasmic viral factories
of the ER which produces double stranded RNA. This double stranded RNA then
undergoes transcription to form additional single stranded RNA. This new single
stranded RNA is then assembled in the ER to form new virions. These virions are
ultimately transferred to the Golgi and released and go on and infect new cells (14).
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Polyamines
Polyamines are small, positively charge molecules found in all cells. They consist
of flexible carbon chains with positively charged amino groups. Polyamines are involved
in diverse cellular processes including protein synthesis, RNA folding, membrane
interactions, protein-RNA interactions, DNA structure, and gene expression(16, 17).
Mammalian cells synthesize three biogenic polyamines: putrescine, spermidine, and
spermine. All three polyamines are synthesized through the same pathway. The first
step occurs when arginine is converted to ornithine. Ornithine is then converted into
putrescine via the gatekeeping enzyme of the pathway, ornithine decarboxylase 1
(ODC1). Putrescine is then converted to spermidine by the enzyme spermidine
synthase (SRM). Spermidine is ultimately converted to spermine via the enzyme
spermine synthase (SMS)(18). The cell exerts a significant amount of energy in
maintaining polyamine homeostasis. This is done through synthesis, degradation,
import, and export of polyamines. This homeostasis is maintained by the enzymes
polyamine oxidase (PAOX), ODC1 antizyme (OAZ1), and spermidine/spermine
acetyltransferase 1 (SAT1) in a tightly controlled feedback mechanism (19) (Figure 4).

7

Figure 4. Biosynthesis Pathway of Polyamines.
Polyamine synthesis begins with arginine being converted into ornithine. ODC1, the
rate-limiting enzyme, converts ornithine to putrescine. Putrescine is converted to
spermidine via SRM. Spermidine is converted to spermine via SMS and converted back
via SMOX. Spermine and spermidine can be acetylated by SAT1 and converted back to
putrescine via PAO. Image adapted and modified from(20).
Considering the importance of polyamines in cellular processes, it is not
surprising that viruses also utilize polyamines during their lifecycle (18). Viruses rely on
polyamines for numerous stages in the viral life cycle including genome packaging,
DNA-dependent RNA polymerization, genome replication, and viral protein translation.
DNA viruses like herpes simplex 1 (HSV1) and human cytomegalovirus (HCMV) have
been shown to rely on polyamines for replication (21, 22). Vaccinia virus has also been
shown to rely on polyamines in a late step of its viral lifecycle (23). The role of
polyamines in RNA viruses has been demonstrated in several different virus families
including alphaviruses, enteroviruses, bunyaviruses, and flaviviruses (24, 25).
Bunyaviruses, La Crosse virus (LACV) and Rift Valley fever virus (RVFV), have been
shown to generate noninfectious viral particles when polyamines are deleted from the
cell(26). Replication of these viruses was impacted to various degrees when polyamines
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were depleted from the cell making the polyamine pathway a possible target for limiting
viral infections(18).
SAT1
Spermidine/spermine acetyltransferase (SAT1) is the rate-limiting enzyme in the
interconversion of polyamines. SAT1 works by acetylating spermidine and spermine
which results in their degradation or excretion from the cell. SAT1 uses acetyl-CoA to
acetylate the aminopropyl end of these higher level polyamines. In the presence of high
levels of polyamines, transcription and translation of SAT1 are increased. SAT1 has
been shown to be induced in response to many different agents and pathophysiological
conditions including polyamines analogs such as N1, N1 -diethylnorspermine (DENSpm)
and the interferon response (24, 27). The interferon response, which is the innate
immune response to viral infection, initiates a series of signaling events that results in
the expression of interferon-stimulated genes (ISGs), including SAT1, to counteract viral
infection. Studies have shown that SAT1 is upregulated with interferon beta treatment of
cells, which results in the depletion of polyamines from the cell and limits viral infection
(24).
SAT1 is regulated, by polyamines and their analogs, at many different levels of
gene expression including transcription and stabilization of messenger RNA (mRNA).
The Sat1 gene contains six exons that encode mRNAs of 1.3 and 1.5 kb. SAT1 premRNA has been shown to undergo alternative splicing to yield a longer variant (SAT1X). Studies have shown that inclusion of this exon is inhibited by polyamines and their
analogs resulting in a stable and correct mRNA. This longer variant has an additional
110bp exon between exon 3 and exon 4. This exon introduces three in-frame premature
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termination codons which marks it for nonsense mediated mRNA decay (28) (Figure 5).
Previous studies have shown that SAT1-X mRNA is accumulated upon various factors
including X-ray irradiation (29), iron chelation, hypoxia (30), and infection with
Venezuelan equine encephalitis virus and tick-borne encephalitis virus (31). However, it
is unknown if this longer SAT1 variant is induced upon ZIKV infection.

Figure 5. Alternatively Spliced SAT1.
SAT1 has been shown to be alternatively spliced to yield a longer variant. This is due to
the addition of an exon about 110 bp long between exons 3 and 4 indicated in purple.
This additional exon introduced three premature termination codons indicated in red.
The normal SAT1 transcript encodes a protein of about 171 amino acids. Due to
the presence of three premature stop codons, the alternatively spliced variant is only
capable of producing a 71 amino acid polypeptide (31) (Figure 6). It has been reported
that 68 amino acid residues of the N-terminus of the tSAT1 are identical to the fulllength SAT but due to a shift in the reading frame from the addition 110 bp, tSAT1 has a
new C-terminus. This reconstructed C- terminus of tSAT1 lacks both the acetyl-CoA
binding and catalytic motifs which are essential for polyamine regulation (30). Thus, it is
likely tSAT1 is not antiviral though that has not been reported.
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Figure 6. Truncated SAT1 Protein
The normal SAT1 transcript encodes a protein of about 171 amino acids, SAT1-X is
only capable of producing a 71 amino acid polypeptide. This truncated polypeptide
(tSAT1) is the result of a reading frame shift that introduces three premature stop
codons (31).
Hypothesis and Aims
Studies have shown that RNA viruses, such as ZIKV, rely on polyamines for
replication and depletion of these polyamines results in decreased viral replication. It
has also been shown that SAT1 is induced upon the interferon response to viral
infection. SAT1 reduces polyamine levels in the cell by acetylating spermidine and
spermine, marking them for degradation or excretion. This ultimately restricts viral
replication by depleting the cell of polyamines (24). Furthermore, studies have shown
that SAT1 can be alternatively spliced in response to polyamine analogs and other
pathophysiological agents including some RNA viruses (31). This alternative splice
variant introduces three premature termination codons which results in nonsense
mediated mRNA decay (28). We hypothesized that ZIKV induces alternative splicing of
SAT1, generating an enzyme that is nonfunctional and thus allowing robust virus
infection by disrupting polyamine depletion.
In AIM 1, we measured SAT1 induction and its effects on polyamine levels during
ZIKV infection. I hypothesized that ZIKV infection would cause SAT1 induction and
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there would be a decrease in polyamine levels due to SAT1 activation. The results from
this aim determined how viral infection and polyamine catabolism interrelate.
In AIM 2, we determined the mechanism of SAT1 inactivation during viral
infection. I hypothesized that ZIKV was inducing alternative splicing of SAT1, creating
the longer variant carrying three premature termination codons. The results from this
aim determined how ZIKV may be inhibiting SAT1 function.
In AIM 3, we measured SAT1 splicing in multiple cell types and with different
viruses. I hypothesized that that immune signaling would play an important role in the
induction of SAT1 and that this would be a conserved mechanism for viruses from
different families. The results from this aim determined if SAT1 alternative splicing is
induced through interferon signaling.
The data generated from these aims will define a novel interaction between host
cells and ZIKV. We see that ZIKV does induce alternative splicing of SAT1 which
prevents the cell from regulating polyamine levels during a viral infection.

CHAPTER TWO
MATERIALS AND METHODS
Cell Culture
Cells were maintained at 37⁰C in 5% CO2, in Dulbecco’s modified Eagle’s
medium (DMEM; Life Technologies) with bovine serum and penicillin-streptomycin.
Vero cells (BEI Resources) were supplemented with 10% new-born calf serum (NBCS;
Thermo-Fisher) and Huh7 cells, kindly provided by Dr. Susan Uprichard, were
supplemented with 10% fetal bovine serum (FBS; Thermo-Fisher). THP1 cells were
donated by Dr. Makio Iwashima and maintained in RPMI (Thermo-Fisher)
supplemented with 2% FBS and beta-mercaptoethanol (BME, 50mM; Thermo-Fisher).
THP1’s were differentiated with phorbol 12-myristate 13-acetate (PMA, 100 pg/ mL;
Thermo-Fisher).
Drug Treatment
N1,N11-Diethylnorspermine (DENSpm; Santa Cruz Biotechnology) were diluted
to 100x solution (100mM and 10mM, respectively) in sterile water. Cells were treated
with 100uM of DENSpm 24 hours before, 2 hours after, and 4 hours after infection.
During infection, media was cleared and saved from the cells. The same medium
containing DENSpm was then used to replenish the cells following infection. Cells were
incubated at the appropriate temperature for the duration of the infection.
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Infection and Enumeration of Viral Titers
RVFV and LACV were derived from the first passage of virus in Huh7 cells. ZIKV
(MR766) was derived from the first passage of virus in Vero cells. ZIKV and LACV were
obtained from Biodefense and Emerging Infections (BEI) Research Resources. For all
infections, DENSpm was maintained throughout infection as designated. Viral stocks
were maintained at -80⁰C. For infection, virus was diluted in serum-free DMEM for a
multiplicity of infection (MOI) of 5 on Huh7 cells, unless otherwise indicated. Viral
inoculum was overlain on cells for 10 to 30 minutes, and the cells were replenished with
media. Supernatants were collected from MP-12, LACV, and ZIKV 24 hpi. Dilutions of
cell supernatant were prepared in serum-free DMEM and used to inoculate confluent
monolayer of Vero cells for 10 to 15 min at 37⁰C. Cells were overlain with 0.8% agarose
in DMEM containing 2% NBCS. MP-12, ZIKV, and LACV samples incubated for 3 days
at 37⁰C. Following incubation, cells were fixed with 4% formalin and revealed with
crystal violet solution (10% crystal violet; Sigma-Aldrich). Plaques were enumerated and
used to back-calculate the number of plaque forming units (pfu) per milliliter of collected
volume.
Thin Layer Chromatography Determination of Polyamines
Polyamines were separated by thin-layer chromatography as previously
described (Madhubala, 1998). For all samples, cells were treated as described prior to
being trypsinized and centrifuged. Pellets were washed with PBS and then resuspended
in 200 uL 2% perchloric acid. Samples were then incubated overnight at 4⁰C. 200 uL of
supernatant was combined with 200 uL 5 mg/ml dansyl chloride (Sigma Aldrich) in
acetone and 100 uL saturated sodium bicarbonate. Samples were incubated in the dark
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overnight at room temperature. Excess dansyl chloride was cleared by incubating the
reaction with 100 µL 150 mg/mL proline (Sigma Aldrich). Dansylated polyamines were
extracted with 50 µL toluene (Sigma Aldrich) and centifuged. 5 µL of sample was added
in small spots to the TLC plate (silica gel matrix; Sigma Aldrich) and exposed to
ascending chromatography with 1:1 cyclohexane: ethylacetate. Plate was dried and
visualized via exposure to UV.
RNA Purification and cDNA Synthesis
Cells were collected in Trizol reagent (Zymo Research). RNA was purified with a
phenol-chloroform extraction, DNase treated (Invitrogen), and used for cDNA synthesis
using Multiscribe reverse transcriptase (Applied Biosystems), with 500 ng RNA and
random hexamer primers.
Gene Expression Analysis
RNA from cells was collected and purified. Gene expression was analyzed by
quantitative real-time PCR with SYBR Green (DotScientific) using a one-step protocol
using QuantStudio 3 (ThermoFisher Scientific). Relative gene expression was
calculated using the ΔCT method, normalized to GAPDH qRT-PCR control. Primers
were verified for linearity using eight-fold serial diluted cDNA and checked for specificity
via melt curve analysis following by agarose gel electrophoresis.
Splicing Analysis
RNA from cells was collected and purified. Splicing was analyzed by real-time
PCR with DreamTaq (DotScientific) using SimpliAmp Thermal Cycler (Applied
Biosystems by Life technologies). PCR product was analyzed by agarose gel
electrophoresis.
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Table 1. Primers Used in This Study
Primers

Forward

Reverse

SAT1

5’-GAAGAGGTGCTTCTGATCTGTC-3’

5’-CTCACTCCTCTGTTGCCATTT-3’

tSAT1

5’-GTCTCTAGCTTCGCCATGTA-3’

5’-CTAGGAAATGTGTTATTTCATC-3’

ZIKV

5’-CCCTCAAGTATAGCAGCAAGAG-3’

5’-TGAGTTGGAGTCCGGAAATG-3’

β-Actin

5’-CACTCTTCCAGCCTTCCTTC-3’

5’-GTACAGGTCTTTGCGGATGT-3’

Western Blots
Samples were collected with Bolt LDS Buffer and Bolt Reducing Agent
(Invitrogen) and run on polyacrylamide gels. Gels were transferred using the semi-dry
transfer method. Membranes were probed with primary antibody for GAPDH (1:5000,
proteintech) and SAT1 (1:100, Santa Cruz Biotechnology). Membranes were treated
with SuperSignal West Pico PLUS Chemiluminescent Substrate (ThermoFisher
Scientific) and visualized on ProteinSimple FluorChem E imager.
Polyamine Luciferase Reporter Assay
To measure free polyamine levels in cells, a dual-luciferase vector containing the
wild-type -1 frameshift antizyme OAZ1 (pC5730), were transfected into cells with
LipoD293 (SignaGen). Free polyamines modulate OAZ1 mRNA frameshifting and these
constructs can measure relative endogenous polyamine concentrations via a dualluciferase reporter as previously described (32). Huh7 cells were seeded with 2% media
and drug treated as described above. Cells were transfected with 62.5 ng of reporter
plasmid of and after 24 hours of incubation, luminescent signal was measured using the
Dual-Luciferase Reporter Assay System (Promega) by measuring both firefly and
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Renilla luciferase with the Veritas Microplate Luminometer (Turner Biosystems). Firefly
luciferase was normalized to Renilla and the wild-type values and subsequently
normalized to untreated controls.
Transfection of Plasmids
Primers were designed to target SAT1 with overlapping ends. Gibson assembly
was used to generate plasmid with tetracycline promoter.
Quantification and Statistical Analysis
Prism 6 (GraphPad) was used to generate graphs and perform statistical
analysis. For all analyses, one-tailed Student’s t test was used to compare groups,
unless otherwise noted in figure legends, with a = 0.05. For tests of sample proportions,
p values were derived from calculated Z scores with two tails and a = 0.05. Correlations
between SAT1 expression and viral titer were calculated using either the linear
regression or exponential growth curve fitting function of Prism. Statistical details are
noted in individual figure legends. Mean and standard error of the mean are shown in
figures. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, NS p > 0.05.
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CHAPTER THREE
RESULTS
SAT1 is Induced Upon Viral Infection
The interferon response, triggered by viral infection, leads to a series of signaling
events that results in the expression of interferon stimulated genes (ISGs). These ISGs
counteract the viral infection in several different ways, including degrading viral mRNA,
altering membranes, and inducing apoptosis. Studies have shown that SAT1 is
upregulated in response to interferon beta treatment of cells (24). To investigate if SAT1
is induced upon viral infection, we infected PMA derived macrophages (THP1) with
ZIKV, LACV, or the vaccine strain of RVFV at a multiplicity of infection (MOI) of 5 plaque
forming units (pfu) per cell. Samples were collected after 24 hours and SAT1 induction
was measured via qRT-PCR with SAT1 specific primers. We observed a significant
increase in SAT1 gene expression in cells infected with virus (Figure 7A). This
experiment was also done in huh7 cells. We observed a similar phenotype in which
SAT1 gene expression was significantly increased in cells infected with virus (Figure
7B). This suggests that SAT1 is induced in response to infection with ZIKV, LACV, and
RVFV.
SAT1 is the rate-limiting enzyme in the interconversion of polyamines. SAT1
works by acetylating spermidine and spermine, which results in their degradation or
excretion from the cell (18). Since SAT1 is induced upon viral infection, we sought to
determine polyamine levels during a viral infection. Considering that SAT1 is induced,
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we hypothesized that the higher-level polyamines (spermine and spermidine) would not
be present in infected cells. We infected THP1 cells with ZIKV, LACV, or RVFV at a
MOI of 5 and collected after 24 hours and performed thin-layer chromatography (TLC)
on polyamines. We found that, compared to our positive control of DENSpm treated
cells, which showed no spermine or spermidine, virus infected cells still had these
higher-level polyamines present (Figure 7C). This suggests that while SAT1 is induced
transcriptionally upon viral infection, it is not functioning to acetylate spermine or
spermidine for degradation or excretion.
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Figure 7. SAT1 is Induced Upon Viral Infection.
(A) THP1 cells were infected with ZIKV, LACV, or RVFV at a MOI of 5. Samples were
collected after 24 hours. Following RNA purification, SAT1 gene expression was
measure via qRT-PCR and normalized to cellular β-Actin. (B) Huh7 cells were infected
with ZIKV, LACV, or RVFV at a MOI of 5 and collected after 24 hours. Following RNA
purification, SAT1 gene expression was measured via qRT-PCR. (C) Thin layer
chromatography on THP1 cells infected as in (A) to measure biogenic polyamine levels.
Values provided above data bars represent the fold change compared to untreated
conditions. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001 using Student’s t test (n ≥ 3) comparing
infection to uninfected controls. Error bars represent ± 1 SEM. Statistical comparison
were performed between infected and uninfected conditions.
DENSpm-mediated SAT1 Induction Does Not Alter Viral Replication After
Infection Initiates
Previous studies have shown that flaviviruses, including ZIKV, rely on
polyamines for a productive infection (25). Our data suggests that, even though SAT1 is
induced during a viral infection, the enzyme is not acetylating the higher-level
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polyamines marking them for excretion or degradation. We sought to see the effects on
viral replication if we forced the expression of SAT1 using DENSpm. DENSpm is a
polyamine analog and induces SAT1. We treated THP1 cells with 100 μM DENSpm
either 24 hours before, 2 hours after, or 4 hours after infection with ZIKV at a MOI of 5.
After 24 hours, we titered the samples on Vero-E6 cells. We found that, compared to
our not treated samples, the samples treated with DENSpm 24 hours before infection
had a decrease in viral replication indicating the antiviral effects of SAT1. However,
when cells are treated with DENSpm 2- or 4-hours after infection, the viral titers have
not decreased when compared to not treated samples (Figure 8A). This was repeated in
Huh7 cells and the same phenotype was observed, when cells were treated before
infection, the viral titers were decreased but when the cells were treated at either time
point after infection, the viral titers did not decrease (Figure 8B). To visually confirm that
it is the polyamine levels being affected by the DENSpm treatment, we performed a
TLC on samples from THP1 cells. The cells were once again treated with 100 μM
DENSpm 24 hours before, at the time of infection, 2 hours after, or 4 hours after
infection with ZIKV. The samples were collected after 24 hours and TLC on the
polyamines was performed. We found that when cells are treated with 100 μM DENSpm
24 hours before infection, there is no spermidine or spermine in the samples. When
cells are treated at or after infection however, spermidine and spermine are present in
the samples (Figure 8C). This is suggesting that if SAT1 is induced after viral infection
has initiated, it is not acetylating spermidine and spermine, marking them for excretion
or degradation.
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Figure 8. DENSpm-mediated SAT1 Induction Does Not Alter Polyamine Levels
After Infection Initiates.
(A) THP1 cells were treated with DENSpm 24 hours before, 2 hours after, or 4 hours
after infection with ZIKV. Samples were collected after 24 hours and titered via plaque
assay. (B) Huh7 cells were treated with DENSpm 24 hours before, 2 hours after, and 4
hours after infection with ZIKV. Samples were collected after 24 hours and titered via
plaque assay. (C) Thin layer chromatography on cells treated and infected as in (A) to
measure biological polyamine levels. Values provided above data bars represent the
fold change compared to untreated conditions. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001 using
Student’s t test (n ≥ 3) comparing DENSpm treated to untreated controls. Error bars
represent ± 1 SEM. Statistical comparison were performed between treated and
untreated conditions.
To ensure that SAT1 is being induced in these samples, we performed the same
time of DENSpm addition as before on THP1 cells and collected the samples 24 hours
after infection with ZIKV. We then measured SAT1 induction via qRT-PCR using SAT1
specific primers. We found that in all samples treated with DENSpm, there was an
induction of SAT1 compared to not treated samples (Figure 9A). This indicates that,
regardless of when samples are treated with DENSpm relative to viral infection, SAT1 is
being induced. We also looked at protein levels via western blot analysis using the
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same experimental setup. We found that when cells are treated with DENSpm before
infection there is SAT1 present but after infection the amount of SAT1 protein seems to
decrease with time (Figure 9B). The cause and effect of this is unclear at this time and
further investigation is needed. Together, these data suggests that, once virus infection
is initiated, SAT1 is induced, yet its induction does not result in the exportation or
degradation of spermidine and spermine and therefore, is not antiviral.

Figure 9. SAT1 is Induced Upon DENSpm Treatment After Infection is Initiated.
(A) THP1 cells were treated with DENSpm 24 hours before, 2 hours after, or 4 hours
after infection with ZIKV. Samples were collected after 24 hours and gene expression
was measured via qRT-PCR and normalized to cellular β-Actin. (B) Western blot
analysis of samples treated and infected as in (A). Values provided above data bars
represent the fold change compared to untreated conditions. *p ≤ 0.05, **p ≤ 0.01, ***p
≤ 0.001 using Student’s t test (n ≥ 3) comparing DENSpm treated to untreated controls.
Error bars represent ± 1 SEM. Statistical comparison were performed between treated
and untreated conditions.
SAT1 Splicing is Altered with Infection
SAT1 is regulated by polyamines at many different levels of gene expression,
including transcription and stabilization of mRNA. Previous studies have shown that
SAT1 pre-mRNA can undergo alternative splicing. This alternative splicing produces a
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longer variant (SAT1-X) by insertion of an additional exon between exons 3 and 4. The
additional exon carries three pre-mature stop codons, marking it for nonsense-mediated
RNA decay (Figure 5) (28). This variant has been shown to be induced by tick-borne
encephalitis virus and Venezuelan equine encephalitis virus, both of which are RNA
viruses (31). We hypothesized that ZIKV also induces the alternative splicing of SAT1 to
generate a nonfunctional enzyme and prevent the degradation of polyamines. To test
this hypothesis, we performed a time course of ZIKV infection. We infected THP1 cells
and collected samples 2 hours, 4 hours, 8 hours, 16 hours, and 24 hours after infection
followed by RNA purification and qRT-PCR using primers specific to SAT1 and SAT1-X,
the alternatively-spliced variant. We found that, as expected, as infection progressed
there was an increase in SAT1 expression (Figure 10A). We also found that as infection
progressed, there was also an increase of SAT1-X expression (Figure 10B). To
visualize this, we also performed RT-PCR with primers specific for SAT1 on these
samples. We found that all samples had SAT1, however as the infection progresses, we
found the presence of an additional SAT1 band (Figure 10C). This band is about 110 bp
larger than the normal SAT1 band suggesting it is SAT1-X. This suggests that ZIKV
infection does result in alternative splicing of SAT1 to produce a larger variant by
insertion of an additional exon.
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Figure 10. SAT1 Splicing is Altered with ZIKV Infection.
(A) THP1 cells were infected with ZIKV and samples were collected after 2 hours, 4
hours, 8 hours, 16 hours, and 24 hours. RNA was purified and total SAT1 gene
expression was measured via qRT-PCR and normalized to β-Actin and uninfected cells.
(B) qRT-PCR with primers specific to SAT1-X was performed on samples from (A).
(C) RT-PCR was performed on samples from (A) and run on an agarose gel. Values
provided above data bars represent the fold change compared to untreated conditions.
*p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001 using Student’s t test (n ≥ 3) comparing infection to
uninfected controls. Error bars represent ± 1 SEM. Statistical comparison were
performed between infected and uninfected conditions.
We further explored this phenotype in LACV and RVFV as well as Huh7 cells.
Our previous data showed that SAT1 is induced in LACV and RVFV infections, but the
polyamine levels were not altered by expression. We hypothesized that infection with
these viruses also results in the alternative splicing of SAT1. We infected Huh7 or THP1
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cells with LACV or RVFV and collected samples after 24 hours. We purified RNA and
performed qRT-PCR using SAT1-X specific primers. We found that both viruses
induced the expression of SAT1-X in THP1, specifically RVFV had a high induction of
this variant (Figure 11A). We found infection with these viruses also results in the
expression of SAT1-X in Huh7 cells as well (Figure 11B). To visualize this, we
performed RT-PCR on these THP1 samples and ran them on an agarose gel. We found
the presence of an additional band about 110 bp larger than the standard SAT1 band,
indicating the presence of the additional exon (Figure 11C). These data suggests that
this phenotype is not specific to ZIKV and that RVFV and LACV infections also results in
the alternative splicing of SAT1 to generate a nonfunctional enzyme that does not alter
polyamine levels in the cell.
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Figure 11. SAT1 Splicing is Altered with LACV and RVFV Infection.
(A) THP1 cells were infected with ZIKV, LACV, or RVFV and collected after 24 hours.
RNA was purified and SAT1-X expression was measured via qRT-PCR and normalized
to β-Actin and uninfected. (B) Huh7 cells were infected with ZIKV, LACV, or RVFV and
collected after 24 hours. RNA was purified and SAT1-X expression was measured via
qRT-PCR. (C) RT-PCR was performed on samples from (A) and run on an agarose gel.
Values provided above data bars represent the fold change compared to untreated
conditions. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001 using Student’s t test (n ≥ 3) comparing
infection to uninfected controls. Error bars represent ± 1 SEM. Statistical comparison
were performed between infected and uninfected conditions.
Alternatively Spliced SAT1 is Not Antiviral
Our previous data has shown that SAT1 is alternatively spliced with viral
infection. This splice variant introduces an additional 110 bp exon between exons 3 and
4 which introduces a reading frame shift resulting in three premature termination codons
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ultimately marking the mRNA for nonsense-mediated mRNA decay (28). While the Nterminus of tSAT1 is identical to SAT1, the C-terminus lacks both the acetyl-CoA and
catalytic motifs required for polyamine regulation (30). Therefore, we hypothesized that
tSAT1 would not be antiviral due to its inability to acetylate polyamines marking them for
degradation. Using the process of Gibson assembly, we were able to generate a
plasmid carrying tSAT1. To investigate tSAT1’s effects on polyamine levels, we
transfected increasing amounts of tSAT1 plasmid into 293T cells and measured
polyamine levels using a quantitative polyamine-sensitive luciferase assay. We found
that regardless of how much tSAT1 plasmid we transfected in, there was no reduction in
polyamine levels (Figure 12A). This suggests that tSAT1 does not reduce polyamine
levels in the cell. We further wanted to look at the tSAT1’s effects during virus infection.
To do this, we transfected cells with 100ng of tSAT1 along with 100 ng of ZIKV fulllength infectious clone plasmids. After 24 hours, we measured ZIKV viral genomes via
qPCR. We found that while SAT1 decreased the amount of viral genomes, tSAT1 had
no effect when compared to controls (Figure 12B). These data suggest that tSAT1 is not
antiviral, though more experiments are necessary to conclude this.

28

Figure 12. tSAT1 Does Not Reduce Polyamine Levels and is Not Antiviral.
(A) 293T cells were transfected with 100 ng, 500 ng, or 1000 ng of tSAT1 plasmid and
intracellular polyamine levels were measured using dual luciferase assay reporter of an
OAZ1 transcript construct. Relative luciferase activity was normalized to untransfected
cells. (B) Huh7 cells were transfected with 100 ng of tSAT1 plasmid and 100 ng of ZIKV
protein plasmids, viral genome was measured with qRT-PCR and normalized to
untransfected samples. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001 using Student’s t test (n ≥ 3)
comparing untransfected cells to transfected cells. Error bars represent ± 1 SEM.
Statistical comparison were performed between transfected and untransfected
conditions.
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CHAPTER FOUR
DISCUSSION
ZIKV Induces Alternative Splicing of SAT1
Previous studies have shown that RNA viruses, such as ZIKV, rely on
polyamines for replication and depletion of these polyamines results in decreased viral
replication. It has also been shown that SAT1 is induced upon the interferon response
to viral infection. SAT1 reduces polyamine levels in the cell by acetylating spermidine
and spermine, marking them for degradation or excretion. This ultimately restricts viral
replication by depleting the cell of polyamines (24). Furthermore, studies have shown
that SAT1 can be alternatively spliced in response to polyamine analogs and other
pathophysiological agents including some RNA viruses (31). Our goal was to determine
if ZIKV induces the alternative splicing of SAT1 to prevent the acetylation of higher-level
polyamines. Our data suggests that during ZIKV infection, SAT1 is induced via
interferon signaling but does not acetylate spermidine/spermine marking them for
degradation or excretion from the cell. Furthermore, our data suggest that SAT1 is
alternatively spliced, generating a longer variant with the addition of a 110 bp exon. This
newly included exon creates a reading frame shift that introduces three premature stop
codons and thus a truncated protein. We further demonstrated that this truncated
protein might not be antiviral. We have generated a working model in which ZIKV
utilizes polyamines during its infection cycle, as a way to combat this, type 1 interferon
signals to activate SAT1. SAT1 then acetylates spermidine/spermine marking them for
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degradation or export from the cell. However, ZIKV can induce alternative splicing of
SAT1, generating a truncated version which prevents the export of these polyamines,
allowing the virus to use them during its lifecycle. (Figure 13).

Figure 13. Proposed Model of SAT1 Alternative Splicing during ZIKV Infection.
SAT1 is induced during a ZIKV infection through type 1 interferon signaling. SAT1 then
acetylated spermidine/spermine marking them for degradation or export from the cell.
ZIKV however, induces the alternative splicing of SAT1 generating a truncated version
that does not result in the acetylation of these polyamines and thus allows the virus to
use them during its lifecycle.
We further observed this phenotype in other RNA virus families, including
bunyaviruses such as LACV and RVFV. Both of these also induced alternative splicing
of SAT1 during infection. This indicates that this may be a conserved mechanism
among viruses. In addition to bunyaviruses, other studies observed this alternative
splicing of SAT1 in alphaviruses including Semliki Forest virus and Venezuelan equine
encephalitis virus (28, 31).
Proposed Mechanism of Alternative Splicing of SAT1
During a viral infection, viral proteins work to subvert various cellular processes,
remodels intracellular membranes, alters metabolic pathways to block the innate
immune response. One could suggest that the alternative splicing of SAT1, the key
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enzyme in polyamine regulation, could be another way the virus disarms the innate
immune response. How the virus does this remains unknown and further investigation
would be required to answer this question. However, recent studies have shown the
NS5 protein of dengue virus (DENV), another flavivirus very similar to ZIKV, to interact
with the spliceosome in infected cells. In this study, the researchers found the DENV
NS5 protein to interact with the uridine-rich small nuclear ribonucleoprotein particles U5
(U5 snRNP) to moderate splicing. They revealed differences in splicing of transcripts
involved in innate immune responses and cell cycle control, including a few ISGs;
however, SAT1 was not on the list of proteins they investigated (33). Another study,
which delved into the molecular mechanism underlying SAT1 alternative splicing upon
DENV infection found similar results to what our data suggests. The researchers
observed lower protein levels of RBM10, a splicing factor responsible for SAT1 exon 4
skipping, during infection. They reported the NS5 DENV protein interacts with RBM10
and triggers RBM10 proteasome-mediated degradation. By over-expressing RBM10 in
virus infected cells, they observed limited viral replication and no changes to SAT1
splicing. Whereas RBM10 depletion resulted in increased SAT1 splicing and an
increase in viral replication (34). Another study looked at the localization of ZIKV
proteins during an infection and found the NS5 protein localizes to the nucleus and
promotes trafficking of the splicing factor SC35 (35). This suggests that the ZIKV NS5
protein may play a role in regulating the gene splicing process in host cells. During a
viral infection, ZIKV relies on many host machinery and resources during its life cycle
(18). We could hypothesize that it would be beneficial to disarm the interferon response
within the host cell. By targeting the spliceosome or the components of gene splicing,
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the interferon response would be hindered for the benefit of the virus. Our data supports
this hypothesis and includes SAT1 among other ISGs. By generating a non-functional
SAT1, the polyamine levels, which ZIKV relies on, would not be diminished, allowing the
virus to continue to use them and have a robust infection.
Physiological Role of tSAT1
The alternative splice variant of SAT1 has been reported during times of cellular
stress, including X-ray irradiation (29), iron deficiency, or hypoxia (30). One study
indicated that cells stably over-expressing the splice variant were protected from
apoptosis under iron-deficient conditions (30). This brings into question the
physiological role of the splice variant. One study showed that the splice variant is a
target for non-sense mediated mRNA decay due to the introduction of three premature
stop codons (28). This would ultimately prevent any production of new SAT1 protein to
decrease polyamine levels. If the splice variant mRNA was not degraded, it would
generate a truncated protein (termed here as tSAT1) that is only the first 71 N-terminal
amino acids (31). tSAT1 would lack both the acetyl-CoA binding and catalytic motifs,
which are essential for polyamine regulation (30). Another possibility of how tSAT1
disrupts polyamine regulation is that active SAT1 is an oligomeric protein (36) and
tSAT1 could bind to the enzyme as a defective subunit. This would, in turn, inhibit SAT1
function. Regardless of how tSAT1 prohibits polyamine export and degradation, the
alternative splicing of SAT1 may contribute to cell survival. Considering the splice
variant has been induced during different unfavorable conditions, it is hypothesized to
be a defense mechanism of the cell to prevent apoptosis (30). If this is the case, it is not
surprising tSAT1 is induced during a viral infection. Viruses rely on the host for
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replication and preventing cellular apoptosis would allow the virus to continue its
lifecycle.
It would be interesting to further explore the role of tSAT1 by generating a cell
line carrying this truncated protein. This would allow for further investigation into its
effects on polyamine levels in the cell. This cell line would also provide insight into if the
truncated protein is antiviral or not. It would also be beneficial to generate a cell line
carrying a version of SAT1 that cannot undergo alternative splicing. We further want to
explore if the NS5 ZIKV protein is responsible for the alternative splicing of SAT1 as it
has been suggested in DENV infection.
While there are many avenues to explore involving the alternative splicing of
SAT1 during a viral infection, our data has provided insight into the dynamic relationship
between virus and host. Understanding how the virus neutralizes the innate immune
system can provide insight into both the mechanisms of viral infection and the host
response, in addition to highlighting novel therapeutic routes.

REFERENCE LIST
1.

Hayes EB. Zika Virus Outside Africa - Volume 15, Number 9—September 2009 Emerging Infectious Diseases journal - CDC.

2.

Duffy MR, Chen TH, Hancock WT, Powers AM, Kool JL, Lanciotti RS. 2009. Zika
Virus Outbreak on Yap Island, Federated States of Micronesia | NEJM 360:253643.

3.

Zika Virus, French Polynesia, South Pacific, 2013 - Volume 20, Number 6—June
2014 - Emerging Infectious Diseases journal - CDC.

4.

Bogoch II, Brady OJ, Kraemer MUG, German M, Creatore MI, Kulkarni MA,
Brownstein JS, Mekaru SR, Hay SI, Groot E, Watts A, Khan K. 2016. Anticipating
the international spread of Zika virus from Brazil. Lancet Lond Engl 387:335–336.

5.

WHO | Zika situation report. WHO.

6.

Potential of selected Senegalese Aedes spp . mosquitoes ( Diptera : Culicidae ) to
transmit Zika virus | BMC Infectious Diseases.

7.

Diallo D, Sall AA, Diagne CT, Faye O, Faye O, Ba Y, Hanley KA, Buenemann M,
Weaver SC, Diallo M. 2014. Zika Virus Emergence in Mosquitoes in Southeastern
Senegal, 2011. PLOS ONE 9:e109442.

8.

Petersen EE, Staples JE, Meaney-Delman, D, Fischer M, Ellington SR, Callaghan
WM, Jamieson DJ. 2016. Interim Guidelines for Pregnant Women During a Zika
Virus Outbreak — United States, 2016. MMWR Morb Mortal Wkly Rep 65:30–33.

9.

Martins e Silva D, Nunes MK. 2016. Zika Virus Infection: New Findings Related to
Neurological Complications. J Neonatal Biol 05.

10.

Yuki N, Hartung H-P. 2012. Guillain–Barré Syndrome. N Engl J Med 366:2294–
2304.

11.

Malone RW, Homan J, Callahan MV, Glasspool-Malone J, Damodaran L,
Schneider ADB, Zimler R, Talton J, Cobb RR, Ruzic I, Smith-Gagen J, Janies D,
Wilson J. 2016. Zika Virus: Medical Countermeasure Development Challenges.
PLoS Negl Trop Dis 10.

34

35

12.

Qian X, Nguyen HN, Song MM, Hadiono C, Ogden SC, Hammack C, Yao B,
Hamersky G, Jacob F, Zhong C, Yoon K, Jeang W, Lin L, Li Y, Thakor J, Berg D,
Zhang C, Kang E, Chickering M, Naeun D, Ho C-Y, Wen Z, Christian KM, Shi PY, Maher BJ, Wu H, Jin P, Tang H, Song H, Ming G. 2016. Brain Region-specific
Organoids using Mini-bioreactors for Modeling ZIKV Exposure. Cell 165:1238–
1254.

13.

Haddow AD, Schuh AJ, Yasuda CY, Kasper MR, Heang V, Huy R, Guzman H,
Tesh RB, Weaver SC. 2012. Genetic Characterization of Zika Virus Strains:
Geographic Expansion of the Asian Lineage. PLoS Negl Trop Dis 6.

14.

Hamel R, Dejarnac O, Wichit S, Ekchariyawat P, Neyret A, Luplertlop N, PereraLecoin M, Surasombatpattana P, Talignani L, Thomas F, Cao-Lormeau VM,
Briant L, Despres P, Amara A, Yssel H, Misse D. 2015.Biology of Zika Virus
Infection in Human Skin Cells. J Virol 89: 8880-8896

15.

Buckley A, Gould EA. 1988. Detection of virus-specific antigen in nuclei or
nucleoli of Cells Infected with ZIKa or Langat Virus. Journal of General Virology.
69:1913-1920.

16.

Pegg AE. 2009. Mammalian Polyamine Metabolism and Function. IUBMB Life
61:880–894.

17.

Frugier M, Florentz C, Hosseini MW, Lehn JM, Giegé R. 1994. Synthetic
polyamines stimulate in vitro transcription by T7 RNA polymerase. Nucleic Acids
Res 22:2784–2790.

18.

Mounce BC, Olsen ME, Vignuzzi M, Connor JH. 2017. Polyamines and Their
Role in Virus Infection. Microbiol Mol Biol Rev MMBR 81.

19.

Control of ornithine decarboxylase activity in stimulated human lymphocytes by
putrescine and spermidine | Biochemical Journal | Portland Press.

20.

Brooks WH. 2013. Increased Polyamines Alter Chromatin and Stabilize
Autoantigens in Autoimmune Diseases. Front Immunol 4.

21.

Gibson W, van Breemen R, Fields A, LaFemina R, Irmiere A. 1984. D,L-alphadifluoromethylornithine inhibits human cytomegalovirus replication. J Virol
50:145–154.

22.

Pohjanpelto P, Sekki A, Hukkanen V, von Bonsdorff CH. 1988. Polyamine
depletion of cells reduces the infectivity of herpes simplex virus but not the
infectivity of Sindbis virus. Life Sci 42:2011–2018.

23.

Williamson JD. 1976. The effect of methylglyoxal bis(guanylhydrazone) on
vaccinia virus replication. Biochem Biophys Res Commun 73:120–126.

36

24.

Mounce BC, Poirier EZ, Passoni G, Simon-Loriere E, Cesaro T, Prot M,
Stapleford KA, Moratorio G, Sakuntabhai A, Levraud J-P, Vignuzzi M. 2016.
Interferon-Induced Spermidine-Spermine Acetyltransferase and Polyamine
Depletion Restrict Zika and Chikungunya Viruses. Cell Host Microbe 20:167–177.

25.

Mounce BC, Cesaro T, Moratorio G, Hooikaas PJ, Yakovleva A, Werneke SW,
Smith EC, Poirier EZ, Simon-Loriere E, Prot M, Tamietti C, Vitry S, Volle R, Khou
C, Frenkiel M-P, Sakuntabhai A, Delpeyroux F, Pardigon N, Flamand M, BarbaSpaeth G, Lafon M, Denison MR, Albert ML, Vignuzzi M. 2016. Inhibition of
Polyamine Biosynthesis Is a Broad-Spectrum Strategy against RNA Viruses. J
Virol 90:9683–9692.

26.

Mastrodomenico V, Esin JJ, Graham ML, Tate PM, Hawkins GM, Sandler ZJ,
Rademacher DJ, Kicmal TM, Dial CN, Mounce BC. 2019. Polyamine depletion
inhibits bunyavirus infection via generation of noninfectious interfering virions. J
Virol JVI.00530-19.

27.

Porter CW, Ganis B, Libby PR, Bergeron RJ. Correlations between Polyamine
Analogue-induced Increases in Spermidine/ Spermine A^-Acetyltransferase
Activity, Polyamine Pool Depletion, and Growth Inhibition in Human Melanoma
Cell Lines 7.

28.

Hyvönen MT, Uimari A, Keinänen TA, Heikkinen S, Pellinen R, Wahlfors T,
Korhonen A, Närvänen A, Wahlfors J, Alhonen L, Jänne J. 2006. Polyamineregulated unproductive splicing and translation of spermidine/spermine N1acetyltransferase. RNA 12:1569–1582.

29.

Accumulation of spermidine/spermine N1‐acetyltransferase and alternatively
spliced mRNAs as a delayed response of HeLa S3 cells following X‐ray
irradiation: International Journal of Radiation Biology: Vol 80, No 5.

30.

Kim K, Ryu J-H, Park J-W, Kim M-S, Chun Y-S. 2005. Induction of a SSAT
isoform in response to hypoxia or iron deficiency and its protective effects on cell
death. Biochem Biophys Res Commun 331:78–85.

31.

Nikiforova NN, Velikodvorskaja TV, Kachko AV, Nikolaev LG, Monastyrskaya GS,
Lukyanov SA, Konovalova SN, Protopopova EV, Svyatchenko VA, Kiselev NN,
Loktev VB, Sverdlov ED. 2002. Induction of Alternatively Spliced
Spermidine/Spermine N1-Acetyltransferase mRNA in the Human Kidney Cells
Infected by Venezuelan Equine Encephalitis and Tick-Borne Encephalitis Viruses.
Virology 297:163–171.

32.

Ivanov IP, Shin B-S, Loughran G, Tzani I, Young-Baird SK, Cao C, Atkins JF,
Dever TE. 2018. Polyamine Control of Translation Elongation Regulates Start
Site Selection on Antizyme Inhibitor mRNA via Ribosome Queuing. Mol Cell
70:254-264.e6.

33.

Maio FAD, Risso G, Iglesias NG, Shah P, Pozzi B, Gebhard LG, Mammi P,

37

Mancini E, Yanovsky MJ, Andino R, Krogan N, Srebrow A, Gamarnik AV. 2016.
The Dengue Virus NS5 Protein Intrudes in the Cellular Spliceosome and
Modulates Splicing. PLOS Pathog 12:e1005841.
34.

Pozzi B, Bragado L, Mammi P, Torti MF, Gaioli N, Gebhard LG, Garcia Sola ME,
Vaz-Drago R, Iglesias NG, Garcia CC, Gamarnik AV, Srebrow A. 2020. Dengue
virus targets RBM10 deregulation host cell splicing and innate immune response.
Nucleic Acids 10.1093.

35.

Hou W, Cruz-cosme R, Armstrong N, Obwolo LA, Wen F, Hu W, Luo M-H, Tang
Q. 2017. Molecular cloning and characterization of the genes encoding the
proteins of Zika virus | Elsevier Enhanced Reader.

36.

Libby PR, Ganis B, Bergeron RJ, Porter CW. 1991. Characterization of human
spermidine/spermine N1-acetyltransferase purified from cultured melanoma cells.
Arch Biochem Biophys 284:238–244.

VITA
The author, Marion Graham, was born in Durand, Michigan on March 28th, 1996
to Brenda and Nathan Graham. She attended Eastern Michigan University in Ypsilanti,
Michigan where she earned a Bachelor of Science in Biology with a minor in Chemistry.
She matriculated to Loyola University Chicago in July 2018, in the Microbiology and
Immunology MS program where she joined the lab of Dr. Bryan Mounce.
Marion’s work focused on investigating the gene expression of SAT1 during a
viral infection. After completion of her Master of Science degree, Marion will attend
Rush University and continue her training in the Integrated Biomedical Sciences
doctoral program.

